A phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects.

Zev M NakamuraAllison M DealEliza M ParkKate E StantonYesy E LopezLaura J QuillenErin O'Hare KellyHillary M HeilingKirsten A NyropEmily M RayE Claire DeesKatherine E Reeder-HayesTrevor A JollyLisa A CareyYara G AbdouOludamilola A OlajideJulia K RauchRanjit JosephAnureet CopelandMegan A McNamaraTim A AhlesHyman B Muss

Published in: Cancer medicine (2023)

ClinicalTrials.gov NCT04033419.

Keyphrases

phase ii
cognitive decline
open label
early breast cancer
clinical trial
mild cognitive impairment
phase iii
placebo controlled
double blind
study protocol
locally advanced
squamous cell carcinoma
radiation therapy
rectal cancer